Braun-Bostich & Associates’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-442
Closed -$7K 240
2020
Q2
$7K Hold
442
0.01% 240
2020
Q1
$3K Hold
442
﹤0.01% 269
2019
Q4
$8K Buy
+442
New +$7.34K 0.01% 256
2019
Q3
Sell
-442
Closed -$11K 118
2019
Q2
$11K Hold
442
0.01% 254
2019
Q1
$16K Hold
442
0.02% 249
2018
Q4
$12K Hold
442
0.01% 247
2018
Q3
$17K Hold
442
0.02% 243
2018
Q2
$20K Hold
442
0.02% 221
2018
Q1
$22K Hold
442
0.02% 210
2017
Q4
$22K Buy
+442
New +$23.2K 0.02% 216

Other funds holding CC

Braun-Bostich & Associates's CC Position: Q3 2020 in Review

Braun-Bostich & Associates sold out of Chemours (CC) in Q3 2020, closing a stake of 442 shares — an estimated $7K sold.

Braun-Bostich & Associates first reported a position in CC in Q4 2017 and held it in 10 quarters. The position peaked at $22K in Q1 2018. 384 funds tracked by Wall St. Rank hold CC as of Q3 2020.

  • Braun-Bostich & Associates reported no remaining Chemours position as of Q3 2020 after selling out during the quarter.
  • Braun-Bostich & Associates sold 442 Chemours shares in Q3 2020, an estimated $7K.
  • Braun-Bostich & Associates first reported a position in Chemours in Q4 2017 and held it in 10 quarters.
  • Braun-Bostich & Associates's Chemours position peaked at $22K in Q1 2018.
  • 384 funds tracked by Wall St. Rank held Chemours as of Q3 2020.

Based on Braun-Bostich & Associates's 13F filing for Q3 2020, filed 9 Oct 2020.